UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence

Faecal Incontinence Clinical Trial

— CONFIDeNT  

Official title:

CONtrol of Faecal Incontinence Using Distal NeuromodulaTion (CONFIDeNT)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02349334
• Other study ID #: 34825
• Secondary ID: 09/104/16
• Status: Completed
• Phase: Phase 3
• First received: January 23, 2015
• Last updated: January 27, 2015
• Start date: January 2012
• Est. completion date: September 2014

Study information

• Verified date: January 2015
• Source: Queen Mary University of London
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: National Health Service
• Study type: Interventional

Clinical Trial Summary

Faecal incontinence occurs when a person passes faeces (stools) without the usual control. It is a distressing condition that is actually very common although under-reported because of embarrassment. Milder symptoms may be managed by treatments such as dietary change, drugs and bowel retraining, but many patients still resort to surgery to improve symptoms. Although several operations exist to treat incontinence e.g. those aiming to repair damaged anal sphincter muscles, it is now clear that these often have poor results.

Two relatively new treatments called sacral nerve stimulation (SNS) and percutaneous tibial nerve stimulation (PTNS) involve sending pulses of electricity to the nerves controlling the bowel and muscles of the anus (anal sphincter).

SNS does this by inserting electrodes in the lower back just above the tailbone and connecting them to an implanted electrical stimulator which is buried in the buttock and acts a bit like a heart pacemaker. SNS is a relatively well-established treatment in specialist centres, which has been used for over 10 years. It has been shown in studies to be successful for faecal incontinence achieving some improvement in at least three quarters of patients. In Europe, this procedure is fast becoming first treatment offered when non-surgical treatments fail. Nevertheless, SNS is not a miracle cure for all, requiring 2 operations, with potential complications and expensive equipment (> £10,000 approx).

PTNS is a newer treatment, which involves electrically stimulating a nerve at the ankle, using a very small needle, as an outpatient (a bit like acupuncture). This sends signals back to the spine region to try and improve symptoms of faecal incontinence. Since this is a newer treatment, fewer studies have been performed to quantify how successful it is, but early results of PTNS suggest that it may be as good as SNS. If this is true, this is very important because it is much less invasive and considerably cheaper than SNS (equipment £500 per patient).

This project will for the first time determine how effective PTNS is in the treatment of patients with faecal incontinence, by comparing it to sham (fake stimulation). This study is a properly designed clinical trial of 212 patients in at least 14 UK Specialist Centres.. The results of this trial will lead to direct benefits for patients and the NHS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 227
• Est. completion date: September 2014
• Est. primary completion date: February 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Faecal incontinence sufficiently severe enough to warrant intervention

• Failure of appropriate conservative therapies

• Age = 18 years

Exclusion Criteria:

• Inability to provide informed consent for the research study

• Inability to fill in the detailed bowel diaries required for outcome assessments (this will exclude participants who do not speak / read English)*

• Neurological diseases, such as diabetic neuropathy, multiple sclerosis and Parkinson's disease (any participant with painful peripheral neuropathy)

• Anatomical limitations that would prevent successful placement of needle electrode

• Other medical conditions precluding stimulation: e.g. bleeding disorders, certain cardiac pacemakers, peripheral vascular disease or ulcer, lower leg cellulitis

• Congenital anorectal anomalies or absence of native rectum due to surgery

• A cloacal defect

• Present evidence of external full thickness rectal prolapse

• Previous rectal surgery (rectopexy / resection) done < 12 months ago (24 months for cancer),

• Stoma in situ

• Chronic bowel diseases such as inflammatory bowel disease leading to chronic uncontrolled diarrhoea

• Pregnancy or intention to become pregnant

• Previous experience of SNS or PTNS

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Bowel Incontinence
• Faecal Incontinence
• Fecal Incontinence

Intervention

Device:
• Percutaneous Tibial Nerve Stimulation

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Queen Mary University of London

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Primary outcome: Binary - success or failure based on % patients achieving > or = 50% reduction in faecal incontinence episodes	From 2 weekly bowel diaries before and after treatment	3 months	No
Secondary	Reduction in faecal incontinence episodes		3 months	No
Secondary	Proportion of patients achieving >25%, >75% and 100% reduction in faecal incotinence episodes		3 months	No
Secondary	Reduction in Cleveland Clinic Constipation Score		3 months	No